Oxford University Hospitals NHS Foundation Trust

Specialist MDT: Oxford University Hospitals NHS Foundation Trust

View Provider Services

Men diagnosed at this hospital trust can access the following services (updated 2022):

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Transrectal ultrasound (TRUS) biopsy
    • Choline PET
    • PSMA (prostate-specific membrane antigen) PET scan
    • Whole body MRI
    • Isotope bone scan
  • Treatment Facilities:
    • Radical prostatectomy
    • Robot assisted laparoscopic prostatectomy
    • External beam radiotherapy (EBRT)
    • Stereotactic body radiation therapy (SBRT)
    • Chemotherapy
    • Joint specialist MDT clinic
  • Support Service Facilities:
    • Clinical Nurse Specialist (CNS) in all clinics
    • Prostate cancer-specific CNSs
    • Advanced PCa CNS
    • Urology CNS
    • Sexual function services
    • Specialist continence services
    • Genetic counselling

Data Quality

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 433 880
Performance Status recorded 46% 53%
PSA completed 50% 41%
Gleason Score completed 81% 83%
TNM completed 81% 73%

Disease Presentation

Specialist MDT National
No. of men with disease status determined 778 31258
Percentage of men diagnosed with metastatic disease 21% 19%

Management

Specialist MDT National
No. of men diagnosed with low-risk localised disease 75 3680
Percentage of men with low-risk localised disease receiving radical treatment 0% 9%
No. of men diagnosed with locally advanced disease 264 11503
Percentage of men diagnosed with locally advanced disease receiving radical treatment 70% 69%

Outcome

Treatment Centre
No. of men who received radical prostatectomy (Apr 2021 - Mar 2022) 151
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 21%
No. of men who received radical prostatectomy (Sep 2019 - August 2020) 148
Adjusted percentage of men experiencing at least one GU complication (%) 12%
No. of men who received radical radiotherapy (Sep 2019 - August 2020) 272
Adjusted percentage of men experiencing at least one GI complication (%)

Compare provider outcomes